EMEA (Europe, Middle East and Africa) Expressed Competent Cells Market Report 2017

December 2017 | 116 pages | ID: E3018E43454EN
QYResearch

Abstracts

In this report, the EMEA Expressed Competent Cells market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Expressed Competent Cells for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Expressed Competent Cells market competition by top manufacturers/players, with Expressed Competent Cells sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Merck KGaA
• Thermo Fisher Scientific
• Agilent Technologies
• Takara Bio
• Promega Corporation
• Beijing TransGen Biotech
• GeneScript Corporation
• Yeastern Biotech
• New England Biolabs
• QIAGEN N.V.
• OriGene Technologies
• Lucigen
• Zymo Research
• Bio-Rad Laboratories
• Bioline
• Delphi Genetics
• IBA GmBH
• Cell Applications
• BioDynamics Laboratory
• Scarab Genomics

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Chemically Competent Cells
• Electrocompetent Cells

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Protein Expression
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Expressed Competent Cells Market Report 2017

1 EXPRESSED COMPETENT CELLS OVERVIEW

1.1 Product Overview and Scope of Expressed Competent Cells
1.2 Classification of Expressed Competent Cells
  1.2.1 EMEA Expressed Competent Cells Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Expressed Competent Cells Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Chemically Competent Cells
  1.2.4 Electrocompetent Cells
1.3 EMEA Expressed Competent Cells Market by Application/End Users
  1.3.1 EMEA Expressed Competent Cells Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Protein Expression
  1.3.3 Other
1.4 EMEA Expressed Competent Cells Market by Region
  1.4.1 EMEA Expressed Competent Cells Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Expressed Competent Cells (2012-2022)
  1.5.1 EMEA Expressed Competent Cells Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Expressed Competent Cells Revenue and Growth Rate (2012-2022)

2 EMEA EXPRESSED COMPETENT CELLS COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Expressed Competent Cells Market Competition by Players/Manufacturers
  2.1.1 EMEA Expressed Competent Cells Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Expressed Competent Cells Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Expressed Competent Cells Sale Price by Players (2012-2017)
2.2 EMEA Expressed Competent Cells (Volume and Value) by Type/Product Category
  2.2.1 EMEA Expressed Competent Cells Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Expressed Competent Cells Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Expressed Competent Cells Sale Price by Type (2012-2017)
2.3 EMEA Expressed Competent Cells (Volume) by Application
2.4 EMEA Expressed Competent Cells (Volume and Value) by Region
  2.4.1 EMEA Expressed Competent Cells Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Expressed Competent Cells Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Expressed Competent Cells Sales Price by Region (2012-2017)

3 EUROPE EXPRESSED COMPETENT CELLS (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Expressed Competent Cells Sales and Value (2012-2017)
  3.1.1 Europe Expressed Competent Cells Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Expressed Competent Cells Revenue and Growth Rate (2012-2017)
3.2 Europe Expressed Competent Cells Sales and Market Share by Type
3.3 Europe Expressed Competent Cells Sales and Market Share by Application
3.4 Europe Expressed Competent Cells Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Expressed Competent Cells Sales Volume by Countries (2012-2017)
  3.4.2 Europe Expressed Competent Cells Revenue by Countries (2012-2017)
  3.4.3 Germany Expressed Competent Cells Sales and Growth Rate (2012-2017)
  3.4.4 France Expressed Competent Cells Sales and Growth Rate (2012-2017)
  3.4.5 UK Expressed Competent Cells Sales and Growth Rate (2012-2017)
  3.4.6 Russia Expressed Competent Cells Sales and Growth Rate (2012-2017)
  3.4.7 Italy Expressed Competent Cells Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Expressed Competent Cells Sales and Growth Rate (2012-2017)

4 MIDDLE EAST EXPRESSED COMPETENT CELLS (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Expressed Competent Cells Sales and Value (2012-2017)
  4.1.1 Middle East Expressed Competent Cells Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Expressed Competent Cells Revenue and Growth Rate (2012-2017)
4.2 Middle East Expressed Competent Cells Sales and Market Share by Type
4.3 Middle East Expressed Competent Cells Sales and Market Share by Application
4.4 Middle East Expressed Competent Cells Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Expressed Competent Cells Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Expressed Competent Cells Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Expressed Competent Cells Sales and Growth Rate (2012-2017)
  4.4.4 Israel Expressed Competent Cells Sales and Growth Rate (2012-2017)
  4.4.5 UAE Expressed Competent Cells Sales and Growth Rate (2012-2017)
  4.4.6 Iran Expressed Competent Cells Sales and Growth Rate (2012-2017)

5 AFRICA EXPRESSED COMPETENT CELLS (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Expressed Competent Cells Sales and Value (2012-2017)
  5.1.1 Africa Expressed Competent Cells Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Expressed Competent Cells Revenue and Growth Rate (2012-2017)
5.2 Africa Expressed Competent Cells Sales and Market Share by Type
5.3 Africa Expressed Competent Cells Sales and Market Share by Application
5.4 Africa Expressed Competent Cells Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Expressed Competent Cells Sales Volume by Countries (2012-2017)
  5.4.2 Africa Expressed Competent Cells Revenue by Countries (2012-2017)
  5.4.3 South Africa Expressed Competent Cells Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Expressed Competent Cells Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Expressed Competent Cells Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Expressed Competent Cells Sales and Growth Rate (2012-2017)

6 EMEA EXPRESSED COMPETENT CELLS MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Merck KGaA
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Expressed Competent Cells Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck KGaA Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Thermo Fisher Scientific
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Expressed Competent Cells Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Thermo Fisher Scientific Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Agilent Technologies
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Expressed Competent Cells Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Agilent Technologies Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Takara Bio
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Expressed Competent Cells Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Takara Bio Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Promega Corporation
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Expressed Competent Cells Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Promega Corporation Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Beijing TransGen Biotech
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Expressed Competent Cells Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Beijing TransGen Biotech Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 GeneScript Corporation
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Expressed Competent Cells Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 GeneScript Corporation Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Yeastern Biotech
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Expressed Competent Cells Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Yeastern Biotech Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 New England Biolabs
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Expressed Competent Cells Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 New England Biolabs Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 QIAGEN N.V.
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Expressed Competent Cells Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 QIAGEN N.V. Expressed Competent Cells Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 OriGene Technologies
6.12 Lucigen
6.13 Zymo Research
6.14 Bio-Rad Laboratories
6.15 Bioline
6.16 Delphi Genetics
6.17 IBA GmBH
6.18 Cell Applications
6.19 BioDynamics Laboratory
6.20 Scarab Genomics

7 EXPRESSED COMPETENT CELLS MANUFACTURING COST ANALYSIS

7.1 Expressed Competent Cells Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Expressed Competent Cells

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Expressed Competent Cells Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Expressed Competent Cells Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA EXPRESSED COMPETENT CELLS MARKET FORECAST (2017-2022)

11.1 EMEA Expressed Competent Cells Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Expressed Competent Cells Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Expressed Competent Cells Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Expressed Competent Cells Price and Trend Forecast (2017-2022)
11.2 EMEA Expressed Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Expressed Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Expressed Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Expressed Competent Cells Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Expressed Competent Cells Sales Forecast by Type (2017-2022)
11.7 EMEA Expressed Competent Cells Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Expressed Competent Cells
Figure EMEA Expressed Competent Cells Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Expressed Competent Cells Sales Volume Market Share by Type (Product Category) in 2016
Figure Chemically Competent Cells Product Picture
Figure Electrocompetent Cells Product Picture
Figure EMEA Expressed Competent Cells Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Expressed Competent Cells by Application in 2016
Figure Protein Expression Examples
Table Key Downstream Customer in Protein Expression
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Expressed Competent Cells Market Size (Million USD) by Region (2012-2022)
Figure Europe Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Expressed Competent Cells Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Expressed Competent Cells Revenue (Million USD) Status and Forecast by Countries
Figure Africa Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Expressed Competent Cells Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Expressed Competent Cells Sales Volume and Growth Rate (2012-2022)
Figure EMEA Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Expressed Competent Cells Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Expressed Competent Cells Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Expressed Competent Cells Sales Share by Players (2012-2017)
Figure 2016 Expressed Competent Cells Sales Share by Players
Figure 2017 Expressed Competent Cells Sales Share by Players
Figure EMEA Expressed Competent Cells Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Expressed Competent Cells Revenue (Million USD) by Players (2012-2017)
Table EMEA Expressed Competent Cells Revenue Share by Players (2012-2017)
Table 2016 EMEA Expressed Competent Cells Revenue Share by Players
Table 2017 EMEA Expressed Competent Cells Revenue Share by Players
Table EMEA Expressed Competent Cells Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Expressed Competent Cells Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Expressed Competent Cells Sales Share by Type (2012-2017)
Figure Sales Market Share of Expressed Competent Cells by Type (2012-2017)
Figure EMEA Expressed Competent Cells Sales Market Share by Type (2012-2017)
Table EMEA Expressed Competent Cells Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Expressed Competent Cells Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Expressed Competent Cells by Type in 2016
Table EMEA Expressed Competent Cells Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Expressed Competent Cells Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Expressed Competent Cells Sales Share by Application (2012-2017)
Figure Sales Market Share of Expressed Competent Cells by Application (2012-2017)
Figure EMEA Expressed Competent Cells Sales Market Share by Application in 2016
Table EMEA Expressed Competent Cells Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Expressed Competent Cells Sales Share by Region (2012-2017)
Figure Sales Market Share of Expressed Competent Cells by Region (2012-2017)
Figure EMEA Expressed Competent Cells Sales Market Share in 2016
Table EMEA Expressed Competent Cells Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Expressed Competent Cells Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Expressed Competent Cells by Region (2012-2017)
Figure EMEA Expressed Competent Cells Revenue Market Share Regions in 2016
Table EMEA Expressed Competent Cells Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Expressed Competent Cells Revenue and Growth Rate (2012-2017)
Table Europe Expressed Competent Cells Sales (K Units) by Type (2012-2017)
Table Europe Expressed Competent Cells Market Share by Type (2012-2017)
Figure Europe Expressed Competent Cells Market Share by Type in 2016
Table Europe Expressed Competent Cells Sales (K Units) by Application (2012-2017)
Table Europe Expressed Competent Cells Market Share by Application (2012-2017)
Figure Europe Expressed Competent Cells Market Share by Application in 2016
Table Europe Expressed Competent Cells Sales (K Units) by Countries (2012-2017)
Table Europe Expressed Competent Cells Sales Market Share by Countries (2012-2017)
Figure Europe Expressed Competent Cells Sales Market Share by Countries (2012-2017)
Figure Europe Expressed Competent Cells Sales Market Share by Countries in 2016
Table Europe Expressed Competent Cells Revenue (Million USD) by Countries (2012-2017)
Table Europe Expressed Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Europe Expressed Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Europe Expressed Competent Cells Revenue Market Share by Countries in 2016
Figure Germany Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure France Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure UK Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Expressed Competent Cells Sales (K Units) by Type (2012-2017)
Table Middle East Expressed Competent Cells Market Share by Type (2012-2017)
Figure Middle East Expressed Competent Cells Market Share by Type (2012-2017)
Table Middle East Expressed Competent Cells Sales (K Units) by Applications (2012-2017)
Table Middle East Expressed Competent Cells Market Share by Applications (2012-2017)
Figure Middle East Expressed Competent Cells Sales Market Share by Application in 2016
Table Middle East Expressed Competent Cells Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Expressed Competent Cells Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Expressed Competent Cells Sales Volume Market Share by Countries in 2016
Table Middle East Expressed Competent Cells Revenue (Million USD) by Countries (2012-2017)
Table Middle East Expressed Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Middle East Expressed Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Middle East Expressed Competent Cells Revenue Market Share by Countries in 2016
Figure Saudi Arabia Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Expressed Competent Cells Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Expressed Competent Cells Sales (K Units) by Type (2012-2017)
Table Africa Expressed Competent Cells Sales Market Share by Type (2012-2017)
Figure Africa Expressed Competent Cells Sales Market Share by Type (2012-2017)
Figure Africa Expressed Competent Cells Sales Market Share by Type in 2016
Table Africa Expressed Competent Cells Sales (K Units) by Application (2012-2017)
Table Africa Expressed Competent Cells Sales Market Share by Application (2012-2017)
Figure Africa Expressed Competent Cells Sales Market Share by Application (2012-2017)
Table Africa Expressed Competent Cells Sales Volume (K Units) by Countries (2012-2017)
Table Africa Expressed Competent Cells Sales Market Share by Countries (2012-2017)
Figure Africa Expressed Competent Cells Sales Market Share by Countries (2012-2017)
Figure Africa Expressed Competent Cells Sales Market Share by Countries in 2016
Table Africa Expressed Competent Cells Revenue (Million USD) by Countries (2012-2017)
Table Africa Expressed Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Africa Expressed Competent Cells Revenue Market Share by Countries (2012-2017)
Figure Africa Expressed Competent Cells Revenue Market Share by Countries in 2016
Figure South Africa Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Table Merck KGaA Expressed Competent Cells Basic Information List
Table Merck KGaA Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck KGaA Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Merck KGaA Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Merck KGaA Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Thermo Fisher Scientific Expressed Competent Cells Basic Information List
Table Thermo Fisher Scientific Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Thermo Fisher Scientific Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Thermo Fisher Scientific Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Thermo Fisher Scientific Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Agilent Technologies Expressed Competent Cells Basic Information List
Table Agilent Technologies Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Agilent Technologies Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Agilent Technologies Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Agilent Technologies Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Takara Bio Expressed Competent Cells Basic Information List
Table Takara Bio Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Takara Bio Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Takara Bio Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Takara Bio Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Promega Corporation Expressed Competent Cells Basic Information List
Table Promega Corporation Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Promega Corporation Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Promega Corporation Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Promega Corporation Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Beijing TransGen Biotech Expressed Competent Cells Basic Information List
Table Beijing TransGen Biotech Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Beijing TransGen Biotech Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Beijing TransGen Biotech Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Beijing TransGen Biotech Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table GeneScript Corporation Expressed Competent Cells Basic Information List
Table GeneScript Corporation Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GeneScript Corporation Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure GeneScript Corporation Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure GeneScript Corporation Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table Yeastern Biotech Expressed Competent Cells Basic Information List
Table Yeastern Biotech Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Yeastern Biotech Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure Yeastern Biotech Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure Yeastern Biotech Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table New England Biolabs Expressed Competent Cells Basic Information List
Table New England Biolabs Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure New England Biolabs Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure New England Biolabs Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure New England Biolabs Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table QIAGEN N.V. Expressed Competent Cells Basic Information List
Table QIAGEN N.V. Expressed Competent Cells Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure QIAGEN N.V. Expressed Competent Cells Sales (K Units) and Growth Rate (2012-2017)
Figure QIAGEN N.V. Expressed Competent Cells Sales Market Share in EMEA (2012-2017)
Figure QIAGEN N.V. Expressed Competent Cells Revenue Market Share in EMEA (2012-2017)
Table OriGene Technologies Expressed Competent Cells Basic Information List
Table Lucigen Expressed Competent Cells Basic Information List
Table Zymo Research Expressed Competent Cells Basic Information List
Table Bio-Rad Laboratories Expressed Competent Cells Basic Information List
Table Bioline Expressed Competent Cells Basic Information List
Table Delphi Genetics Expressed Competent Cells Basic Information List
Table IBA GmBH Expressed Competent Cells Basic Information List
Table Cell Applications Expressed Competent Cells Basic Information List
Table BioDynamics Laboratory Expressed Competent Cells Basic Information List
Table Scarab Genomics Expressed Competent Cells Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Expressed Competent Cells
Figure Manufacturing Process Analysis of Expressed Competent Cells
Figure Expressed Competent Cells Industrial Chain Analysis
Table Raw Materials Sources of Expressed Competent Cells Major Manufacturers in 2016
Table Major Buyers of Expressed Competent Cells
Table Distributors/Traders List
Figure EMEA Expressed Competent Cells Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Expressed Competent Cells Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Expressed Competent Cells Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Expressed Competent Cells Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Expressed Competent Cells Sales Market Share Forecast by Region (2017-2022)
Table EMEA Expressed Competent Cells Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Expressed Competent Cells Revenue Market Share Forecast by Region (2017-2022)
Table Europe Expressed Competent Cells Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Expressed Competent Cells Sales Market Share Forecast by Countries (2017-2022)
Table Europe Expressed Competent Cells Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Expressed Competent Cells Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Expressed Competent Cells Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Expressed Competent Cells Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Expressed Competent Cells Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Expressed Competent Cells Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Expressed Competent Cells Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Expressed Competent Cells Sales Market Share Forecast by Countries (2017-2022)
Table Africa Expressed Competent Cells Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Expressed Competent Cells Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Expressed Competent Cells Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Expressed Competent Cells Sales Market Share Forecast by Type (2017-2022)
Table EMEA Expressed Competent Cells Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Expressed Competent Cells Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources